University of Groningenfounded in 1614  -  top 100 university
Close
About usHow to find usprof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Dept of Pharmacy & 2ndary appointment Professor UMCG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 36 37576 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

1 - 34 out of 34Page size: 50
  1. Ong, K. J. (2019). Economic aspects of public health programmes for infectious disease control: studies on human immunodeficiency virus & human papillomavirus. [Groningen]: University of Groningen. https://doi.org/10.33612/diss.98545253
  2. Huang, Y. (2019). Use of real-world evidence in pharmacoeconomic analysis: illustrations in The Netherlands and China. [Groningen]: University of Groningen. https://doi.org/10.33612/diss.95669767
  3. Arifin, B. (2018). Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients. [Groningen]: University of Groningen.
  4. van Wijhe, M. (2018). The public health impact of vaccination programmes in the Netherlands: A historical analysis of mortality, morbidity, and costs. [Groningen]: University of Groningen.
  5. Zakiyah, N. (2018). Women's health from a global economic perspective. [Groningen]: University of Groningen.
  6. Setiawan, D. (2017). HPV vaccination in Indonesia: A health-economic & comparative perspective. [Groningen]: University of Groningen.
  7. Fugel, H-J. (2016). Economics of stratified medicine: Challenges and opportunities in adapting stratified medicine approaches to enhance patient access, population health, cost-effectiveness and return on investment. [Groningen]: University of Groningen.
  8. Mafirakureva, N. (2016). Health economics of blood transfusion in Zimbabwe. [Groningen]: University of Groningen.
  9. Nguyen, T. P. L. (2016). Health economics of screening for hypertension in Vietnam. [Groningen]: University of Groningen.
  10. Mihajlovic, J. (2016). Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands. [Groningen]: Rijksuniversiteit Groningen.
  11. Smit, R. (2016). Health economics of tick-borne diseases. [Groningen]: Rijksuniversiteit Groningen.
  12. Dik, J-W. (2016). Impact of medical microbiology: A clinical and financial analysis. [Groningen]: Rijksuniversiteit Groningen.
  13. Mapako, T. (2016). Risk modelling of transfusion transmissible infections. [Groningen]: University of Groningen.
  14. de Vries, F. M. (2016). Statin treatment in type 2 diabetes patients. [Groningen]: Rijksuniversiteit Groningen.
  15. Heeg, B. M. S. (2015). Developing health economic models of chronic diseases for reimbursement purposes. [Groningen]: University of Groningen. https://doi.org/10.1016/j.jval.2014.12.008
  16. van Boven, J. F. M. (2015). Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness. [Groningen]: University of Groningen.
  17. Standaert, B. A. C. G. M. (2015). Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease. [Groningen]: University of Groningen.
  18. Kotsopoulos, N. (2015). Novel economic perspectives on prevention and treatment : case studies for paediatric, adolescent and adult infectious and chronic diseases. [Groningen]: University of Groningen.
  19. Stevanovic, J. (2015). Pharmacoeconomics of cardiovascular disease prevention. [Groningen]: University of Groningen.
  20. Pitman, J. P. (2015). The influence and impact of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) on blood transfusion services in Africa: Case studies from Namibia. [Groningen]: University of Groningen.
  21. Suwantika, A. A. (2014). Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case. [S.l.]: s.n.
  22. Rozenbaum, M. H. (2013). Costs and effectiveness of extended vaccination strategies against pertussis and pneumococcal disease.
  23. Westra, T. A. (2013). Health-economic modelling of human Papillomavirus vaccination. Groningen: [S.n.].
  24. van Hasselt, F. M. (2013). Improving the physical health of people with severe mental illness: the need for tailor made care and uniform evaluation of interventions. Groningen: s.n.
  25. Parouty, M. B. Y. (2013). Inequality aversion to posterity: discounting human lives. Groningen: s.n.
  26. van Hoek, A. J. (2013). The epidemiology and cost-effectiveness of vaccination strategies against infectious diseases: a focus on Varicella zoster, pandemic influenza A/H1N1 2009, and Streptococcus pneumoniae. [S.n.].
  27. Tu, H. A. T. (2012). Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam. Groningen: s.n.
  28. Vegter, S. (2012). The value of personalized approaches to improve pharmacotherapy in renal disease. Groningen: s.n.
  29. Krabbe Lugnér, A. K. (2011). Cost-effectiveness of controlling infectious diseases from a public health perspective. Groningen: s.n.
  30. Connolly, M. P. (2010). The Economics of assisted reproduction: costs and consequences of fertility treatments. Groningen: s.n.
  31. Hubben, G. A. A. (2009). Cost-effectiveness of infectious disease interventions: combining economic modelling and web technology to support decision making. [S.n.].
  32. Boersma, C. (2009). Health economics of cardiovascular & renal disease prevention: from clinical trials to real-life settings. s.n.
  33. de Vries, R. (2009). Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making. Groningen: s.n.
  34. Hulst, M. V. (2008). Health economics of blood transfusion safety. s.n.

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube